Latest Breaking News On - Professor liza thomas - Page 1 : comparemela.com

VYNDAMAX® (tafamidis) PBS-listed for adult patients with wild-type or hereditary transthyretin amyloid cardiomyopathy (ATTR-CM) with New York Heart Association

VYNDAMAX® (tafamidis) PBS-listed for adult patients with wild-type or hereditary transthyretin amyloid cardiomyopathy (ATTR-CM) with New York Heart Association
fnarena.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fnarena.com Daily Mail and Mail on Sunday newspapers.

New zealandNew south walesUnited statesAnne harrisEliza thomasUniversity of new south walesAustralia amyloidosis networkYork heart associationAmerican heart associationAustralian amyloidosis networkConjoint professor at sydney universityPharmaceutical benefits schemeNew york heart associationPfizer australiaProfessor liza thomasConjoint professor

VYNDAMAX® (tafamidis) PBS-listed for adult patients with wild-type or hereditary transthyretin amyloid cardiomyopathy (ATTR-CM) with New York Heart Association (NYHA) Class I-II heart failure

SYDNEY, May 4, 2024 /PRNewswire/ Pfizer Australia has welcomed the announcement that VYNDAMAX® (tafamidis), which is approved in Australia for adult

United statesNew zealandNew south walesEliza thomasAnne harrisConjoint professor at sydney universityAmerican heart associationUniversity of new south walesYork heart associationAustralia amyloidosis networkAustralian amyloidosis networkPharmaceutical benefits schemeNew york heart associationPfizer australiaProfessor liza thomasConjoint professor